Edwards Lifesciences
1,226 hedge funds and large institutions have $38.3B invested in Edwards Lifesciences in 2022 Q4 according to their latest regulatory filings, with 146 funds opening new positions, 396 increasing their positions, 472 reducing their positions, and 140 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $42.4B → $38.3B (-$4.08B)
16% less repeat investments, than reductions
Existing positions increased: 396 | Existing positions reduced: 472
39% less funds holding in top 10
Funds holding in top 10: 18 → 11 (-7)
Holders
1,226
Holding in Top 10
11
Calls
$180M
Puts
$127M
Top Buyers
| 1 | +$363M | |
| 2 | +$182M | |
| 3 | +$172M | |
| 4 |
Two Sigma Advisers
New York
|
+$167M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$156M |
Top Sellers
| 1 | -$846M | |
| 2 | -$389M | |
| 3 | -$358M | |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$223M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$95.4M |